Also trades as: 0A8E.L (LSE) · $vol 0M
XERS NASDAQ
Xeris Biopharma Holdings, Inc.
1W: +0.0%
1M: +5.6%
3M: -3.5%
YTD: -13.2%
1Y: +25.6%
3Y: +123.9%
5Y: +85.5%
$6.19
-0.19 (-2.98%)
Weekly Expected Move ±6.1%
$5
$6
$6
$7
$7
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
📊 Key Metrics
TTM$315M
Revenue
+41.5% YoY
$12M
Net Income
+126.6% YoY
$57M
Free Cash Flow
+309.2% YoY
84.0%
Gross Margin
9.5%
Op. Margin
2.7%
Net Margin
💰 Income Flow
How revenue becomes profit💵 Cash Flow
Where cash goes🏦 Balance Sheet
Assets = Liabilities + Equity📈 Financial Health
Profitability
ROE-150.8%
ROA3.4%
ROIC-60.2%
Valuation
P/E87.6
P/B80.9
EV/EBITDA21.3
Leverage
Debt/Equity2.76
Current Ratio2.19
Interest Cov.1.1x
Quality Scores
Piotroski F7/9
Altman Z0.73
Beneish M-2.67